Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Andrea, Illingworth"'
Publikováno v:
Cytometry Part B: Clinical Cytometry.
Autor:
Pedro Horna, Ulrika Johansson, Katherina Psarra, Richard Torres, Sa A. Wang, Shuguang Huang, Julia Almeida, Kristy L. Wolniak, Fiona E. Craig, Andrea Illingworth
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Introducing a sensitive and specific peripheral blood flow cytometric assay for Sézary syndrome and mycosis fungoides (SS/MF) requires careful selection of assay design characteristics, and translation into a laboratory developed assay through devel
Autor:
D. Robert Sutherland, Fernando Ortiz, Stephen J. Richards, Rakesh Nayyar, Miroslav Benko, Andrea Illingworth, Iuri Marinov
Publikováno v:
Cytometry Part B: Clinical Cytometry. 98:179-192
Background The diagnosis of paroxysmal nocturnal hemoglobinuria (PNH) relies on flow cytometric demonstration of loss of glycosyl-phosphatidyl inositol (GPI)-anchored proteins from red blood cells (RBC) and white blood cells (WBC). High-sensitivity m
Publikováno v:
International Journal of Laboratory Hematology. 41:73-81
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematopoietic stem cell disorder resulting from the somatic mutation of the X-linked phosphatidyl-inositol glycan complementation Class A (PIG-A) gene. Depending on the severity of the mutation in t
Autor:
Katherina Psarra, Ulrika Johansson, Kristy L. Wolniak, Sa A. Wang, Pedro Horna, Andrea Illingworth, Fiona E. Craig, Richard Torres, Julia Almeida
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
A peripheral blood flow cytometric assay for Sézary syndrome (SS) or circulating mycosis fungoides (MF) cells must be able to reliably identify, characterize, and enumerate T‐cells with an immunophenotype that differs from non‐neoplastic T‐cel
Autor:
Iuri Marinov, Graeme Quest, D. Robert Sutherland, Fernando Ortiz, Miroslav Benko, Rakesh Nayyar, Andrea Illingworth
Publikováno v:
Cytometry Part B: Clinical Cytometry. 94:637-651
Background Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare acquired hematopoietic stem cell disorder characterized by an inability to make Glyco-Phosphatidyl-Inositol (GPI)-linked cell surface structures. Fluorescent proaerolysin (FLAER-Alexa488)
Autor:
D. Robert Sutherland, Michael Keeney, Dan Payne, John Andreasen, Paul K. Wallace, Iuri Marinov, Andrea Illingworth, Fernando Ortiz
Publikováno v:
Cytometry Part B: Clinical Cytometry. 94:23-48
Since publication in 2010 of the International Clinical Cytometry Society (ICCS) Consensus Guidelines for detection of Paroxysmal nocturnal hemoglobinuria (PNH) by flow cytometery, a great deal of work has been performed to develop, optimize, and val
Autor:
D. Robert Sutherland, Orianne Wagner-Ballon, Iuri Marinov, Andrea Illingworth, Luigi DelVecchio
Publikováno v:
Cytometry Part B: Clinical Cytometry. 94:49-66
Over the past several years, a diverse group of physicians and other laboratory scientists have developed various recommendations and guidelines regarding best practices for PNH testing. This manuscript is based on these previous recommendations as w
Publikováno v:
Clinics in Laboratory Medicine. 37:855-867
Paroxysmal nocturnal hemoglobinuria (PNH) is an uncommon but frequently debilitating disease that, if untreated, may lead to death in up to 35% of patients within 5 years. Assessment of PNH clone size by flow cytometric analysis has increased in impo
Publikováno v:
European Journal of Haematology. 101:804-806